ZURA BIO LTD ZURA
CLASS A ORD SHS · Common Stock · CUSIP G9TY5A101
- SectorHealth care
- IndustryBiological Products, (No Diagnostic Substances)
- HeadquartersLa Jolla, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once ($293.5k this quarter). Holder counts are more reliable. Shares outstanding: 65.0m as of 2025-11-10, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $4.33. Options: 4 managers hold calls ($372.5k notional), 4 hold puts ($610.1k).
Trends to Q3 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2023 | 3 |
| Q2 2023 | 39 |
| Q3 2023 | 42 |
| Q4 2023 | 45 |
| Q1 2024 | 46 |
| Q2 2024 | 58 |
| Q3 2024 | 78 |
| Q4 2024 | 88 |
| Q1 2025 | 74 |
| Q2 2025 | 65 |
| Q3 2025 | 66 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2023 | 34 | 9 |
| Q1 2024 | 19 | 24 |
| Q2 2024 | 36 | 16 |
| Q3 2024 | 53 | 13 |
| Q4 2024 | 51 | 24 |
| Q1 2025 | 29 | 38 |
| Q2 2025 | 33 | 49 |
| Q3 2025 | 31 | 38 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q4 2024 | $522.0k | $290.5k | 0.56 |
| Q1 2025 | $258 | $15.5k | 60.00 |
| Q2 2025 | $0 | $0 | — |
| Q3 2025 | $372.5k | $610.1k | 1.64 |
Biggest buyers
| JPMORGAN CHASE & CO | Added | +4.6m |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | New | +3.0m |
| Ikarian Capital, LLC | New | +2.1m |
| Affinity Asset Advisors, LLC | Added | +1.1m |
| BOOTHBAY FUND MANAGEMENT, LLC | New | +824.1k |
| SILVERARC CAPITAL MANAGEMENT, LLC | New | +720.5k |
| GREAT POINT PARTNERS LLC | Added | +645.7k |
| MONTANOVA CAPITAL, LLC | Added | +612.0k |
| AMERIPRISE FINANCIAL INC | New | +500.0k |
| Atika Capital Management LLC | New | +276.0k |
Biggest sellers
| Point72 Asset Management, L.P. | Reduced | -1.6m |
| Deep Track Capital, LP | Reduced | -1.5m |
| ADAR1 Capital Management, LLC | Reduced | -345.4k |
| GOLDMAN SACHS GROUP INC | Reduced | -221.0k |
| BlackRock, Inc. | Reduced | -212.5k |
| MILLENNIUM MANAGEMENT LLC | Reduced | -199.6k |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Sold out | -169.2k |
| AQR CAPITAL MANAGEMENT LLC | Reduced | -112.1k |
| TWO SIGMA INVESTMENTS, LP | Reduced | -108.6k |
| Y-Intercept (Hong Kong) Ltd | Sold out | -107.9k |
Biggest calls
| CITADEL ADVISORS LLC | New | $174.9k40.4k shares |
| SIMPLEX TRADING, LLC | New | $131.0k30.3k shares |
| DLD Asset Management, LP | New | $65.7k15.2k shares |
| GROUP ONE TRADING LLC | New | $866200 shares |
Biggest puts
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | New | $411.4k95.0k shares |
| CITADEL ADVISORS LLC | New | $137.7k31.8k shares |
| JANE STREET GROUP, LLC | New | $48.1k11.1k shares |
| SIMPLEX TRADING, LLC | New | $13.0k3.2k shares |
Options at notional value: the value of the shares the contracts control, as filers report them, not what the options cost. Not included in the holders, shares or buying above.
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| AI Biotechnology LLC 13D · may seek influence -1.7 pts · filed 2026-03-02 | 18.2% |
Athanor Capital
13D · may seek influence
no change · filed 2026-01-27
Stated purposeThe securities reported herein were acquired by the Reporting Persons for investment purposes in the ordinary course of business. The Reporting Persons acquired the securities without the purpose or effect of changing or influencing the control of the Issuer and do not have any present plans or proposals that relate to or would result in any of the actions described in Items 4(a) through 4(j) of Schedule 13D. The Reporting Persons may, from time to time, review their investment in the Issuer and may engage in discussions with management or the board of directors of the Issuer regarding the Issuer's business, operations and prospects, subject to applicable law. The Reporting Persons reserve the right to determine in the future whether to change the purpose or purposes described above or wh… Full filing |
15.7% |
| Venrock Healthcare Capital Partners III, L.P. 13G · passive investor no change · filed 2026-05-15 | 9.9% |
| SUVRETTA CAPITAL MANAGEMENT, LLC 13G · passive investor +1.3 pts · filed 2026-05-12 | 9.9% |
Fell to 5% or below in the last year: GREAT POINT PARTNERS LLC (4.4%, 2026-05-15), JPMORGAN CHASE & CO (4.7%, 2026-05-06)
Insider purchases and sales in Q3 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q4 2023 | 0 | — | 1 | $8.0m | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 1 | $496.0k | 0 | — | — |
| Q3 2024 | 0 | — | 2 | $10.5m | — |
| Q4 2024 | 0 | — | 1 | $2.7m | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
| Q3 2025 | 0 | — | 0 | — | — |
None reported in Q3 2025.
Holders, Q3 2025
| Manager | Shares | Change |
|---|---|---|
| JPMORGAN CHASE & CO 0.00% of their portfolio | 9.2m $40.0m | Added +4.6m |
| MONTANOVA CAPITAL, LLC 0.72% of their portfolio | 5.5m $23.7m | Added +612.0k |
| Venrock Adviser, LLC 1.13% of their portfolio | 4.6m $20.1m | Unchanged |
| GREAT POINT PARTNERS LLC 6.90% of their portfolio | 3.8m $16.5m | Added +645.7k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. 0.02% of their portfolio | 3.0m $13.2m | New |
| Pfizer Inc 2.94% of their portfolio | 3.0m $12.9m | Unchanged |
| BRAIDWELL LP 0.32% of their portfolio | 2.5m $10.7m | Unchanged |
| Ikarian Capital, LLC 1.87% of their portfolio | 2.1m $9.2m | New |
| ARMISTICE CAPITAL, LLC 0.21% of their portfolio | 1.6m $6.8m | Added +24.0k |
| Affinity Asset Advisors, LLC 0.51% of their portfolio | 1.3m $5.5m | Added +1.1m |
| BOOTHBAY FUND MANAGEMENT, LLC 0.09% of their portfolio | 824.1k $3.6m | New |
| Point72 Asset Management, L.P. 0.01% of their portfolio | 726.3k $3.1m | Reduced -1.6m |
| SILVERARC CAPITAL MANAGEMENT, LLC 0.45% of their portfolio | 720.5k $3.1m | New |
| ADAR1 Capital Management, LLC 0.28% of their portfolio | 652.2k $2.8m | Reduced -345.4k |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 589.7k $2.6m | Reduced -199.6k |
| FMR LLC 0.00% of their portfolio | 531.3k $2.3m | Reduced -37.9k |
| VANGUARD GROUP INC 0.00% of their portfolio | 517.1k $2.2m | Unchanged |
| AMERIPRISE FINANCIAL INC 0.00% of their portfolio | 500.0k $2.2m | New |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 405.3k $1.8m | Reduced -1.9k |
| BlackRock, Inc. 0.00% of their portfolio | 365.7k $1.6m | Reduced -212.5k |
| UBS Group AG 0.00% of their portfolio | 305.3k $1.3m | Added +274.1k |
| Atika Capital Management LLC 0.10% of their portfolio | 276.0k $1.2m | New |
| Deep Track Capital, LP 0.03% of their portfolio | 259.0k $1.1m | Reduced -1.5m |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 255.4k $1.1m | Added +51.3k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.00% of their portfolio | 247.7k $1.1m | Added +129.5k |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 211.9k $917.4k | Added +104.2k |
| MORGAN STANLEY 0.00% of their portfolio | 209.4k $906.8k | Reduced -39.8k |
| STATE STREET CORP 0.00% of their portfolio | 144.4k $625.1k | Unchanged |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 136.3k $590.2k | Reduced -108.6k |
| Alberta Investment Management Corp 0.00% of their portfolio | 133.2k $576.8k | Unchanged |
| TWO SIGMA ADVISERS, LP 0.00% of their portfolio | 119.1k $515.7k | Added +19.0k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 118.0k $510.9k | New |
| DLD Asset Management, LP 0.06% of their portfolio | 100.0k $433.0k | New |
| NORTHERN TRUST CORP 0.00% of their portfolio | 86.4k $374.3k | Reduced -7.7k |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 81.7k $353.9k | Reduced -221.0k |
| CITADEL ADVISORS LLC 0.00% of their portfolio | 80.5k $348.7k | New |
| RBF Capital, LLC 0.02% of their portfolio | 80.0k $346.4k | Reduced -40.0k |
| RAYMOND JAMES FINANCIAL INC 0.00% of their portfolio | 76.6k $331.7k | Reduced -37.6k |
| ACADIAN ASSET MANAGEMENT LLC 0.00% of their portfolio | 65.9k $285.0k | Added +21.0k |
| Cubist Systematic Strategies, LLC 0.00% of their portfolio | 49.4k $213.7k | Added +27.9k |
| AQR CAPITAL MANAGEMENT LLC 0.00% of their portfolio | 44.2k $191.5k | Reduced -112.1k |
| Mariner, LLC 0.00% of their portfolio | 38.8k $167.8k | Added +22.4k |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 31.9k $138.3k | New |
| Squarepoint Ops LLC 0.00% of their portfolio | 25.1k $108.8k | New |
| Forefront Analytics, LLC 0.09% of their portfolio | 21.5k $93.2k | Reduced -42.5k |
| Forefront Wealth Partners, LLC 0.02% of their portfolio | 21.5k $93.2k | New |
| Point72 Asia (Singapore) Pte. Ltd. 0.01% of their portfolio | 18.4k $79.8k | Reduced -12.1k |
| Abel Hall, LLC 0.02% of their portfolio | 13.2k $57.1k | Reduced -153 |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 11.2k $48.6k | Added +1.3k |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 10.7k $46.3k | Reduced -4.9k |
| Scientech Research LLC 0.02% of their portfolio | 10.4k $44.9k | New |
| MAI Capital Management 0.00% of their portfolio | 4.0k $17.3k | Unchanged |
| Clear Street Group Inc. 0.00% of their portfolio | 1.7k $7.3k | First filing |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 1.5k $6.5k | Added +1.3k |
| JONES FINANCIAL COMPANIES LLLP 0.00% of their portfolio | 1.4k $3.3k | Unchanged |
| NISA INVESTMENT ADVISORS, LLC 0.00% of their portfolio | 1.2k $5.2k | Unchanged |
| Steward Partners Investment Advisory, LLC 0.00% of their portfolio | 1.0k $4.3k | New |
| CWM, LLC 0.00% of their portfolio | 838 $4.0k | Reduced -6.1k |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 453 $2.0k | Reduced -101 |
| Essential Partners LLC 0.00% of their portfolio | 292 $1.3k | Reduced -218 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 186 $805 | Reduced -21.8k |
| True Wealth Design, LLC 0.00% of their portfolio | 78 $338 | Reduced -304 |
| CITIGROUP INC 0.00% of their portfolio | 57 $247 | Reduced -9.1k |
| Arax Advisory Partners 0.00% of their portfolio | 36 $155 | New |
| Optiver Holding B.V. 0.00% of their portfolio | 16 $69 | New |
| BARCLAYS PLC 0.00% of their portfolio | 2 $9 | Unchanged |